A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease

✍ Scribed by Paul A. Carpenter; James Lowder; Laura Johnston; Haydar Frangoul; Hanna Khoury; Pablo Parker; Keith R. Jerome; Jeannine S. McCune; Barry Storer; Paul Martin; Frederick Appelbaum; Rafat Abonour; Peter Westervelt; Claudio Anasetti

• Book ID: 118426343
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 256 KB
• Volume: 11
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2005.03.002